Uncategorized
Net sales for Eylea increased 24% in 2016
Regeneron Pharmaceuticals reported U.S. net sales of Eylea increased 15% from $746 million in the fourth quarter of 2015 to $858 million in the fourth quarter of 2016, according to a company press release.Eylea (aflibercept) net sales for the full year were up 24% to $3.323 billion from $2.676 billion in 2015.